Even though the efficacies and phenotypes of the anti-cancer effects of AIMs vary according to the cancer cell types, AIMs inhibited NF-κB activity and the downstream molecules involved in cancer proliferation, anti-apoptosis, invasion and metastasis [13]. This evidence concerns the gene NFKB1 and cancer.